Telix Pharmaceuticals Limited (TLX)
NASDAQ
TLX price, last 12 months
Key stats
- Previous close
- $8.96
- Open
- $8.95
- Day range
- $8.67 – $8.95
- 52-week range
- $6.28 – $13.11
- Volume
- 221.5K
- Avg volume (20 days)
- 284.8K
- Market cap
- $3.1B
Performance
Technicals and fundamentals
About Telix Pharmaceuticals Limited
Telix is a developer of radiopharmaceuticals. Radiopharmaceuticals are specialized drugs containing radioactive isotopes, which are used in both diagnosing and treating cancer. At low doses, these drugs bind to a specific cancer cell and can be visualized through PET imaging. With high doses, they can deliver targeted treatment. Telix has a pipeline of both diagnostics and therapeutics in development. Its pipeline is focused on urologic oncology (prostate, kidney and bladder), neuro-oncology (glioma), musculoskeletal oncology and hematology. Currently, most of the firm's revenue comes from its Illuccix prostate cancer imaging/diagnostic agent.
- Listed on
- NASDAQ
- Market cap
- $3.1B